Hartland & Co »

Neuropace shares owned by Hartland & Co

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $32 2 16.00

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
First Light Asset Management
Morgan Stanley
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
Geode Capital Management
FMR
State Street Corporation
Silvercrest Asset Management Group
Northern Trust

View all funds holding Neuropace